diabetes australia wa
The Future of Diabetes Care Devices Market in 2016 – the key demand drivers remain intact
GBI Research new report "The Future of Diabetes Care Devices Market in 2016 – the key demand drivers remain intact, "provides important data, information and analysis on the global diabetes care devices market, an important segment within the medical technology industry. The medical device report provides market landscape, competitive landscape and market trends, information on two diabetes care devices market categories – Blood glucose monitoring and insulin delivery. The report provides comprehensive information on the major trends that these categories and important analytical content to the dynamics of the market. The report also reviews the competitiveness landscape, key pipeline products and technology offerings. This report was made using data and information proprietary Databases, primary and secondary research and in-house analysis of GBI come Research Team of experts from the industry.
Scope
• Key areas including the U.S. (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
• Global Market size and companies to exchange data three diabetes care devices market categories – blood glucose monitoring and insulin delivery.
• Annualized market income data from 2002 to 2009 forecasts for further seven years until 2016. Shares of the Company for 2008.
• Qualitative analysis of key Market trends, market drivers and limitations of categories and segments.
• Competitive landscape and key company profiles. Main actors include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, Arkray, Terumo, Animas, and Smiths Medical.
• Key pipeline products and technologies expected that the global diabetes care devices market taken in the near future.
Reasons to Buy
• Develop business strategies through the Understanding of trends and developments that are driving the diabetes care market devices worldwide.
• Design and develop your product development, marketing and sales strategies.
• Exploit M & A opportunities by identifying market participants with the most innovative pipeline.
• Development of market entry strategies and Market expansion strategies.
• Identify actors best positioned to take advantage of new market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return on investment.
• What is the next big thing in diabetes care devices Market landscape? – Recognition, use and understand.
• Make more informed decisions from the insightful and detailed analysis of the diabetes care devices market and the factors that shape them.
1 Table of Contents
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction and Overview 11
2.1 Type 1 diabetes 11
2.2 Type 2 Diabetes Title 11
2.3 accentuation Diabetes Cardiovascular Disease 11
2.3.1 Atherosclerosis 11
2.3.2 Diabetic Cardiomyopathy 11
2.3.3 Stroke 11
2.3.4 Renal Disease 12
2.4 Diabetes a burden on the health expenditure 12
2.5 Prevalence and incidence of diabetes 12
2.5.1 Global 12
2.5.2 Diabetes Prevalence in developing countries 13
3 Diabetes Care Devices Market: Market Characterization 14
3.1 Global Diabetes Care Devices Market, Sales ($ m), 2002-2009 14
3.2 Global Diabetes Care Devices Market, earnings forecast ($ m), from 2009 to 2016 15
3.3 Diabetes Care Devices, Key Market Trends 15
3.3.1 Home Health Care Driving Growth in Diabetes Care Devices Market 15
3.3.2 Brand loyalty in Diabetes Care Devices: Hard To achieve 16
3.3.3 reimbursement of expenses Restraining Market 16
3.3.4 Drug Stores to Remain Major Distribution Channels 16
3.4 Diabetes Care Devices: Technology Trends 17
3.4.1 Improvement of Life 17
3.4.2 Continuous Glucose Monitoring (CGM) 18
3.4.3 disposable insulin pumps 18
3.4.4 Pain Free Monitoring Device Drive future growth in Diabetes Care Device Market 20
3.4.5 Increasing demand for insulin Pain Free Delivery Devices 21
3.4.6 Remote Monitoring: Increasing Compliance Diabetic 21
3.5 Diabetes Care Devices, Market Drivers 22
3.5.1 New technologies to increase sales 22
3.5.2 increasing prevalence of diabetes to Boost Sales 23
3.5.3 The aging of the population of the world population to increase patient satisfaction 25
3.5.4 Introduction of new generations of devices to drive the glucose monitoring market 25
3.5.5 Increase the awareness of better diabetes management 26
3.5.6 lifestyle changes to bring about the increase in the prevalence of the disease 26
3.5.7 Product Innovation to increase acceptance 26
26 3.6 Restrictions
3.6.1 Lack of awareness and affordability in developing countries 26
3.6.2 Lack of reimbursement for new technologies 26
3.6.3 Low diagnosis rate was 26
3.6.4 Low patient compliance 27
3.6.5 Total cost is a restraint for insulin pens and pumps 27
3.6.6 Other Factors Restraining the Diabetes Care Devices market was 27
3.6.7 Affecting Growth in low market penetration 27
3.7 Global Diabetes Care Devices Market, Key Company Shares (%) 2008 28
4 Global Diabetes Care Devices Market: Cross-Market Segment Analysis and Forecasts 29
4.1 glucose monitoring market 29
4.1.1 Global Market glucose monitoring, sales ($ m), 2002-2009 29
4.1.2 Global Market glucose measurements, revenue forecasts ($ M), 2009-2016 30
4.1.3 Market Drivers 30
4.1.4 Market restraints 31
4.1.5 Glucose Monitoring Market, Revenue by Segment 32
4.1.6 Blood glucose meters Market Dynamics 33
4.1.7 Test Strips Market Revenue 34
4.1.8 Blood Glucose Strips Market Dynamics 35
4.2 Insulin Delivery Devices 36
4.2.1 Global Delivery Insulin, sales ($ m), Global 2002 to 2009 37
4.2.2 Global Delivery insulin, sales ($ m), Global, 2009-2016 38
4.2.3 Market Drivers 38
4.2.4 Market Restrictions 39
4.2.5 Insulin Pumps Market Revenue 40
4.2.6 Insulin, sales ($ m), Global, 41 forecast
4.2.7 Insulin Pumps Market Dynamics 41
4.2.8 Insulin Pens Market Revenue 42
4.2.9 Insulin Pens Market Dynamics 44
4.2.10 insulin injections, 44 Market Revenue
4.2.11 Insulin Syringes Market Dynamics 45
5 Diabetes Care Devices: Competitive Landscape 46
Competitive Landscape 5.1 insulin delivery system 46
5.1.1 Strategic Assessment 46 competitors
5.1.2 Insulin Delivery Devices, Company Share Analysis (%) 2008 47
5.2 Key issues 47 Companies
5.2.1 Becton, Dickinson and Company 47
5.2.2 Medtronic 47
5.2.3 Novo Nordisk 47
5.2.4 Other 48
5.2.5 Insulet Corporation 48
5.2.6 NiliMEDIX 48
5.2.7 Medingo Ltd 48
5.2.8 Debiotech SA 48
5.2.9 Phluid Corporation 48
5.2.10 Ratio VA 48
5.2.11 insulin Medical Ltd 48
5.2.12 Aradigm Corporation 48
5.2.13 MannKind Corporation 49
5.2.14 Altea Therapeutics Corporation 49
5.3 Glucose Monitoring Systems Market: Competitive Assessment 49
5.3.1 Overview 49
5.3.2 Strategic Assessment 49 competitors
5.3.3 Glucose Monitoring Systems Company Shares 2008 50
5.3.4 F. Hoffmann-La Roche Ltd 50
5.3.5 LifeScan (Johnson & Johnson) 51
5.3.6 Bayer HealthCare 51
5.3.7 Abbott Laboratories 51
5.3.8 Product profiles of the major markets products on the Glucose Monitoring Systems Market 52
5.3.9 OneTouch Ultra Mini 53
5.3.10 Contour 54 meters
6 Global Diabetes Care Devices Market: Cross-country analysis and forecasts 55
6.1 Revenue by country, 2002-2009 55
6.1.1 The U.S. Diabetes Care Devices Market, Sales ($ m), 2002-2009 55
6.1.2 Canada Diabetes Care Devices Market, Sales ($ m), 2002-2009 56
6.1.3 The United Kingdom Diabetes Care Devices Market, Sales ($ m), 2002-2009 57
6.1.4 Germany Diabetes Care Devices Market, Sales ($ m), 2002-2009 58
6.1.5 France Diabetes Care Devices Market, Sales ($ m), 2002-2009 59
6.1.6 Italy Diabetes Care Devices Market, Sales ($ M) 2002-2009 60
6.1.7 Spain Diabetes Care Devices Market, Sales ($ m), 2002-2009 61
6.1.8 Japan Diabetes Care Devices Market, Sales ($ m), 2002-2009 62
6.1.9 China Diabetes Care Devices market, sales ($ m), 2002-2009 63
6.1.10 India Diabetes Care Devices Market turnover (USD million), 2002-2009 64
6.1.11 Australia Diabetes Care Devices Market, Sales ($ m), 2002-2009 65
6.1.12 Brazil Diabetes Care Devices Market turnover (USD million), 2002-2009 66
6.2 earnings forecasts by country, 2009-2016 67
6.2.1 The U.S. Diabetes Care Devices Market, Sales ($ m) 2009-2016 67
6.2.2 Canada Diabetes Care Devices Market, Sales ($ m), 2009-2016 68
6.2.3 The United Kingdom Diabetes Care Devices Market, Sales ($ m) 2009-2016 69
6.2.4 Germany Diabetes Care Devices Market, Sales ($ m), 2009-2016 70
6.2.5 France Diabetes Care Devices Market, Sales ($ m) 2009-2016 71
6.2.6 Italy Diabetes Care Devices Market, Sales ($ m), 2009-2016 72
6.2.7 Spain Diabetes Care Devices Market, Sales ($ m) 2009-2016 73
6.2.8 Japan Diabetes Care Devices Market, Sales ($ m), 2009-2016 74
6.2.9 China Diabetes Care Devices Market, Sales ($ m), of 2009-2016 75
6.2.10 India Diabetes Care Devices Market, Sales ($ m), 2009-2016 76
6.2.11 Australia Diabetes Care Devices Market, Sales ($ m) 2009-2016 77
6.2.12 Brazil Diabetes Care Devices Market, Sales ($ m), 2009-2016 78
7 Diabetes Care Devices: Pipeline Analysis 79
7.1 Glucose Monitoring Key Pipeline Products 79
7.1.1 Strategic Pipeline Assessment 79
7.1.2 Glucose Monitoring Systems – pipeline in the clinical phase of development 80
7.1.3 Profiles of promising devices in clinical development 80
7.1.4 Glucose Monitoring Systems Market: list of pipeline products 83
7.1.5 Glucose Monitoring Systems Product Pipeline summary of product type 86
7.1.6 Glucose Monitoring Systems Product Pipeline Summary: Home Glucose Monitoring Systems 87
7.1.7 Glucose Monitoring System Pipeline Product Summary: Hospital Glucose Monitoring Systems 89
7.1.8 Glucose Monitoring Systems Product Pipeline Summary: Both home and hospital glucose monitoring system 89
7.2 Implications for future market and competition 1990
7.3 Strategic Assessment 1990 competitors
7.4 Glucose Monitoring Systems Market: Emerging Companies in 1991
7.4.1 Introduction 91
7.5 insulin delivery system Key pipeline products 92
7.5.1 Overview 92
7.5.2 Pipeline Strategic Assessment 1993
7.5.3 Insulin Delivery Devices – clinical pipeline in the mode of insulin delivery in 1994
7.6 Insulin Delivery Devices – pipeline in the clinical phase of development 95
Insulin Injection System 7.7 Devices Pipeline Product Summary 96
7.8 Insulin Delivery Devices – Promising Devices in clinical development in 1996
7.8.1 Closed-loop diabetes management system in 1996
7.8.2 Paradigm Veo Systems in 1997
7.8.3 AERx insulin Diabetes Management System 98
7.8.4 Insulin Delivery Devices – Future Market Competition 102
7.8.5 strategic competitor Assessment 102
7.9 Reimbursement for insulin delivery devices 103
8 Global Diabetes Care Devices Market: Consolidation Landscape 105
8.1 Deal Analysis Q1 2009 105
8.1.1 Diabetes Care Devices deals Quarter of 1106
8.2 Deal Analysis Q2 2009 106
8.2.1 Diabetes Care Devices – Deals of Quarter 2107
Deal Analysis 8.3 Q3 2009 108
8.3.1 Diabetes Care Devices – Deals of the Quarter 3109
8.4 Deal Analysis – October 2009 109
8.5 Deal Analysis – December 2009 110
9 Appendix 112
9.1 Decision Support Database 112
9.1.1 Complications of Diabetes 112
9.2 Diabetes Care Devices: Definitions 113
9.2.1 Glucose Monitoring 113
9.2.2 Insulin Injection System 113
9.3 Methodology 113
9.3.1 Secondary Research 114
9.3.2 Primary Research 114
9.3.3 Model 115
9.3.4 Forecasts 115
9.3.5 Expert Panels 115
Contact 115 9.4
9.5 Disclaimer 116
1.1 List of Tables
Table 1: Diabetes mellitus, estimated patient population ('000 'S), 2030 13
Table 2: Diabetes Care Devices, sales ($ m), Global, 2002-2009 14
Table 3: Diabetes Care Devices, turnover (million USD), Global, up from 15 2009 2016
Table 4: Total cost, Traditional Continuous Glucose Meter Glucose Monitor Vs 16
Table 5: disposable insulin pumps, the revenue ($ M), USA, 2005-2009 19
Table 6: disposable insulin pumps, Revenue ($ m), USA, 2009-2015 20
Table 7: Non Invasive Glucose Monitoring Products 21
Table 8: Pain Free Insulin Delivery Products, 2009 21
Table 9: Prevalence Estimates of Diabetes, Global, 2030 23
Table 10: Prevalence of diabetes (Diagnosed and undiagnosed), by age group, USA, 2007 24
Table 11: Prevalence of diabetes (diagnosed and undiagnosed), by sex, USA, 2007 25
Table 12: Population aged over 65 (000 s'), 2005-2010 25
Table 13: Glucose Monitoring, sales ($ m) Global, up from 29 2002 2009
Table 14: Glucose Monitoring, sales ($ m), Global, 2009-2016 30
Table 15: blood glucose monitors, sales ($ m) Global, 2000 – 2009 32
Table 16: blood glucose monitors, sales ($ m), Global, from 2009 to 2016 33
Table 17: Blood glucose test strips, sales ($ m) Global 2002 – 2009 34
Table 18: Blood glucose test strips, sales ($ m), Global, from 2009 to 2016 35
Table 19: Comparison of insulin delivery devices 36
Table 20: Insulin Delivery, sales ($ m), Global, 2002-2009 37
Table 21: Insulin Delivery, sales ($ m), Global, 2009-2016 38
Table 22: Insulin pumps, sales ($ m), Global 2002 to 2009 40
Table 23: insulin pumps, sales ($ m), Global, from 2009 to 2016 41
Table 24: Insulin Pens, sales (Million USD), Global, from 2002 to 2009 43
Table 25: Insulin Pens, Revenue ($ m), Global, 2009-2016 43
Table 26: Insulin Syringes, turnover (million USD), 2002-2009 44 Global
Table 27: Insulin Syringes, sales ($ m), 2009-2016 45 Global
Table 28: Diabetes Care Devices Market, Sales ($ m) U.S., 2002 – 2009 55
Table 29: Diabetes Care Devices Market, Sales ($ m), Canada, 2002-2009 56
Table 30: Diabetes Care Devices Market, Sales ($ m) UK, 2002 – 2009 57
Table 31: Diabetes Care Devices Market, Sales ($ m), Germany, 2002-2009 58
Table 32: Diabetes Care Devices Market, Sales (million USD), France, 2002-2009 59
Table 33: Diabetes Care Devices Market, Sales ($ m), Italy, 2002-2009 60
Table 34: Diabetes Care Devices Market, Turnover (million USD), Spain, 2002-2009 61
Table 35: Diabetes Care Devices Market, Sales ($ m), Japan, 2002-2009 62
Table 36: Diabetes Care Devices Market, Turnover (million USD), China, 2002-2009 63
Table 37: Diabetes Care Devices Market, Sales ($ m), India, 2002-2009 64
Table 38: Diabetes Care Devices Market, Turnover (million USD), Australia, 2002-2009 65
Table 39: Diabetes Care Devices Market, Sales ($ m), Brazil, 2002-2009 66
Table 40: Diabetes Care Devices Market sales (million USD), USA, from 2009 to 2016 67
Table 41: Diabetes Care Devices Market, Sales ($ m), Canada, 2009-2016 68
Table 42: Diabetes Care Devices Market, Sales ($ m), UK, 2009-2016 69
Table 43: Diabetes Care Devices Market, Sales ($ m), Germany, 2009-2016 70
Table 44: Diabetes Care Devices Market, Sales ($ m), France, 2009-2016 71
Table 45: Diabetes Care Devices Market, Sales ($ m), Italy, 2009-2016 72
Table 46: Diabetes Care Devices Market, Revenue ($ M), Spain, 2009-2016 73
Table 47: Diabetes Care Devices Market, Sales ($ m), Japan, 2009-2016 74
Table 48: Diabetes Care Devices Market, Sales ($ m), China, 2009-2016 75
Table 49: Diabetes Care Devices Market, Sales ($ m), India, from 2009 to 2016 76
Table 50: Diabetes Care Devices Market, Sales ($ m), Australia, 2009-2016 77
Table 51: Diabetes Care Devices Market, Sales ($ m), Brazil, 2009 to 2016 78
Table 52: Glucose Monitoring Systems Product Pipeline Summary – I 83
Table 53: Glucose Monitoring Systems Product Pipeline Summary – II 84
Table 54: Glucose Monitoring Systems Product Pipeline Summary – III 85
Table 55: Home Glucose Monitoring Systems Product Pipeline summary – I 87
Table 56: Home glucose monitoring system Pipeline Product Summary – II 88
Table 57: Hospital Glucose Monitoring System Pipeline Product Summary 89
Table 58: Hospital and Home Glucose Monitoring Systems Product Pipeline Summary 89
Table 59: Glucose Monitoring Systems & emerging businesses and products 1991
Table 60: Glucose monitoring system, emerging companies and products – II 1992
Table 61: Insulin Delivery Devices Global Pipeline Product Summary 96
Table 62: closed-loop diabetes management system, product, status 1996
Table 63: Closed-loop diabetes management system, Product 97
Table 64: Paradigm Veo Systems, size and status in 1997
Table 65: Paradigm Veo Systems, Product 97
Table 66: AERx Insulin diabetes management system, product, status 98
Table 67: AERx insulin diabetes management system, product 98
Chart 68: AERx Insulin Diabetes Management System – effect of inhaled insulin (AERx IDMS) plus pioglitazone versus pioglitazone alone on HbA1c in patients with type 2 diabetes in 1999
Table 69: AERx insulin Diabetes Management System – Inhaled human insulin before meals in the AERx IDMS versus sc insulin aspart in Type 2 Diabetes: A 104 Week, Open-Label, Multicenter, randomized study with 12 weeks again randomized study was extended for safety and efficacy 100
Table 70: AERx insulin Diabetes Management System – Inhaled insulin using the AERx IDMS saucepan Versus Subcutaneous Injected insulin aspart in combination with both insulin detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, randomized, parallel group study (of a twelve-week re- Extension Followed randomized study) the safety and efficacy 101
Table 71: Medical Equipment, Diabetes Care Devices, Deals Summary, Q2 2008 – Q1 2009 105
Table 72: Medical Equipment, Diabetes Care Devices, Deals Summary, Q2 2008 – Q2 2009 107
Table 73: Medical Equipment, Diabetes Care Devices, Deals Summary, Q3 2008 – Q3 2009 108
Table 74: Medical Equipment, Diabetes Care Devices, Deals Summary, April 2009 – September 2009 109
Table 75: Medical Equipment, Diabetes Care Devices, Deals Summary, May 2009 – October 2009 110
Table 76: Medical Equipment, Diabetes Care Devices, Deals Summary, June 2009 – November 2009 111
Table 77: Prevalence of diabetes (diagnosed and undiagnosed), by age group, USA, 2007 112
1.2 List of Figures
Figure 1: Diabetes Care Devices, sales ($ m), Global 2002 to 2009 14
Figure 2: Diabetes Care Devices, sales ($ m), Global 2009 to 2016 15
Figure 3: blood glucose meters, distribution channel shares (%) 2008 17
Figure 4: Insulin Delivery, distribution shares (%), 2008 17
Figure 5: disposable insulin pumps, Revenue ($ m), USA, 2005-2009 19
Figure 6: disposable insulin pumps, Revenue ($ m), USA, 2009-2015 20
Figure 7: Diabetes incidence after diagnosis, USA, 2007 24
Figure 8: Diabetic Population by type of treatment, USA, 2007 24
Figure 9: Diabetes Care Devices, Company Share (%), Global, 2008 28
Figure 10: Glucose Monitoring, sales ($ m), Global 2002 to 2009 29
Figure 11: Glucose Monitoring, sales ($ m), Global, 2009-2016 30
Figure 12: blood glucose monitors, sales ($ m), Global, 2000-2009 32
Figure 13: blood glucose monitors, sales ($ m), Global, from 2009 to 2016 33
Figure 14: blood glucose test strips, Revenue ($ m), Global 2002-2009 34
Figure 15: blood glucose test strips, sales ($ m), Global 2009 to 2016 35
Figure 16: Insulin Delivery, sales ($ m), Global 2002 to 2009 37
Figure 17: Insulin Delivery, sales ($ m), Global, 2009-2016 38
Figure 18: insulin pumps, sales ($ m), Global 2002 to 2009 40
Figure 19: insulin pumps, sales ($ m), Global, from 2009 to 2016 41
Figure 20: Insulin Pens, Revenue ($ m), Global 2002 to 2009 42
Figure 21: Insulin Pens, sales ($ m), Global, from 2009 to 2016 43
Figure 22: Insulin Syringes, Revenue ($ M), Global 2002 to 2009 44
Figure 23: Insulin Syringes, sales ($ m), 2009-2016 45 Global
Figure 24: strategic competitive advantages Findings 46th
Figure 25: Insulin Delivery Devices, Company Share Analysis (%) 2008 47
Figure 26: Glucose monitoring, strategic competitive advantages Assessment 49
Figure 27: Glucose Monitoring Systems, Company Shares – 2008 50
Figure 28: Diabetes Care Devices Market, Sales ($ m), U.S., 2002-2009 55
Figure 29: Diabetes Care Devices Market, Sales ($ m), Canada, 2002-2009 56
Figure 30: Diabetes Care Devices Market, Sales ($ m), UK, 2002-2009 57
Figure 31: Diabetes Care Devices Market, Sales ($ m), Germany, 2002-2009 58
Figure 32: Diabetes Care Devices Market, Sales ($ m), France, 2002-2009 59
Figure 33: Diabetes Care Devices Market, Revenue ($ m), Italy, 2002-2009 60
Figure 34: Diabetes Care Devices Market, Sales ($ m), Spain, 2002-2009 61
Figure 35: Diabetes Care Devices Market, Sales ($ m), Japan, 2002-2009 62
Figure 36: Diabetes Care Devices Market, Sales ($ m), China, 2002 – 2009 63
Figure 37: Diabetes Care Devices Market, Sales ($ m), India, 2002-2009 64
Figure 38: Diabetes Care Devices Market, Sales ($ m), Australia, 2002-2009 65
Figure 39: Diabetes Care Devices Market, Sales ($ m), Brazil, 2002-2009 66
Figure 40: Diabetes Care Devices Market, Revenue ($ m), USA, 2009-2016 67
Figure 41: Diabetes Care Devices Market, Sales ($ m), Canada, 2009-2016 68
Figure 42: Diabetes Care Devices Market, Sales (Million USD), Great Britain, 2009-2016 69
Figure 43: Diabetes Care 0044evices Market turnover (USD million), Germany, 2009-2016 70
Figure 44: Diabetes Care Devices Market, Sales ($ m), France, 2009-2016 71
Figure 45: Diabetes Care Devices Market, Sales ($ m), Italy, 2009-2016 72
Figure 46: Diabetes Care Devices Market, Sales ($ m), Spain, 2009-2016 73
Figure 47: Diabetes Care Devices Market, Sales ($ m), Japan, 2009-2016 74
Figure 48: Diabetes Care Devices Market, Sales ($ m), China, 2009-2016 75
Figure 49: Diabetes Care Devices Market, Sales ($ m), India, from 2009 to 2016 76
Figure 50: Diabetes Care Devices Market, Sales ($ m), Australia, 2009-2016 77
Figure 51: Diabetes Care Devices Market, Sales ($ m) Brazil, 2009-2016 78
Figure 52: Technology Trends Analytic Framework 79
Figure 53: Glucose Monitoring Systems – pipeline in the clinical phase of development 80
Figure 54: Glucose monitoring system pipeline product type 86
Figure 55: 90 strategic competitor Assessment
Figure 56: Technology Trends Analytic Framework 93
Figure 57: Technology Trends Analytic Framework – descriptions 94
Figure 58: Insulin Delivery Devices – clinical pipeline in the mode of insulin delivery in 1994
Figure 59: Insulin Delivery Devices pipeline in the clinical phase of development in 1995
Figure 60: Strategic Competitor Assessment 102
Figure 61: Replacement of insulin Delivery Devices 103
Figure 62: reimbursement Mix – 104 insulin pens
Figure 63: Medical Equipment, Diabetes Care Devices, Deal Value and Volume, Q2 2008 – Q1 2009 105
Figure 64: Medical Equipment, Diabetes Care Devices, Deal value and volume, Q2 2008 – Q2 2009 106
Figure 65: Medical Equipment, Diabetes Care Devices, Deal Value and Number of Deals, Q3 2008 – Q3 2009 108
Figure 66: Incidence of diabetes diagnosis, U.S., 2007 112
Figure 67: diabetic patients by Type of treatment, USA, 2007 112
Figure 68: GBI Research Methodology 114
About the Author
The Future of the Diabetes Care Devices Market to 2016 – The Key Demand Drivers Remain Intact now Available on ReportsandReports. ReportsandReports, comprising of an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites.
Diabetes Seattle WA | http://Exfuze-Exfuse.com
